# Study Comparing SUBA™-Itraconazole With SPORANOX® (Itraconazole) in the Treatment of Onychomycosis

> **NCT00791219** · PHASE2 · COMPLETED · sponsor: **Halcygen Pharmaceuticals Limited** · enrollment: 175 (actual)

## Conditions studied

- Onychomycosis

## Interventions

- **DRUG:** SUBA-itraconazole
- **DRUG:** Itraconazole
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT00791219
- **Lead sponsor:** Halcygen Pharmaceuticals Limited
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2008-11
- **Primary completion:** 2010-07
- **Final completion:** 2010-12
- **Target enrollment:** 175 (ACTUAL)
- **Last updated:** 2020-08-25


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00791219

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00791219, "Study Comparing SUBA™-Itraconazole With SPORANOX® (Itraconazole) in the Treatment of Onychomycosis". Retrieved via AI Analytics 2026-06-26 from https://api.ai-analytics.org/clinical/NCT00791219. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*